Nigeria: Nigeria Begins Mass Hpv Vaccinations to Fight Cervical Cancer
[Ghanaian Times] Nigeria has begun a mass vaccination campaign against human papillomavirus (HPV) in a bid to drastically reduce cervical cancer rates. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 26, 2023 Category: African Health Tags: Health and Medicine Nigeria West Africa Source Type: news

MRI-based machine learning nomograms assess cervical cancer risk
MRI-based machine learning-based nomograms can evaluate postoperative risk factors in cervical cancer patients, a study published October 25 in Academic Radiology has found. Researchers led by Zhang Yu from the First Affiliated Hospital of Anhui Medical University in China reported that nomograms based on clinical and imaging parameters performed significantly better than MRI alone in assessing cervical cancer risk factors. “Machine learning-based radiomics have a greater advantage in the prediction of cervical cancer ..., and the combination with incoherent motion diffusion-weighted imaging [IVIM-DWI] and clinical ...
Source: AuntMinnie.com Headlines - October 26, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Source Type: news

Nigeria: It's Mistake to Stop Your Children From Taking HPV Vaccine, Minister Advises
[Premium Times] The Nigerian government launched the HPV vaccine initiative on Tuesday for girls between the ages of nine and 14 years to guard against HPV types 16 and 18, which cause about 70 per cent of cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 26, 2023 Category: African Health Tags: Health and Medicine Nigeria West Africa Source Type: news

Nigeria: Leading the Way - Nigeria's Next Steps On the Path to Cervical Cancer Elimination
[Nigeria Health Watch] Each year, about 12,000 women in Nigeria are diagnosed with cervical cancer, more than half of whom will die. This is an avoidable tragedy for a disease that is preventable, detectable and treatable. As longtime cancer advocates, we hope these devastating numbers will soon dwindle. Yesterday, Nigeria introduced HPV vaccines into its national immunisation programme, taking a critical step towards eliminating the scourge of cervical cancer from our country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 26, 2023 Category: African Health Tags: Health and Medicine Nigeria West Africa Source Type: news

Nigeria: First Lady Decries High Prevalence of Cervical Cancer in Nigeria
[Premium Times] Mrs Tinubu said regular screenings must be encouraged and there must be improved access to healthcare with behavioural interventions. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 25, 2023 Category: African Health Tags: Governance Health and Medicine Nigeria West Africa Source Type: news

Nigeria: First Lady Decries High Prevelance of Cervical Cancer in Nigeria
[Leadership] The First Lady, Mrs Oluremi Tinubu, has expressed deep concern over the alarming prevalence of cervical cancer in Nigeria. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 25, 2023 Category: African Health Tags: Governance Health and Medicine Nigeria West Africa Source Type: news

Nigeria: Cervical Cancer - Nigeria to Reach Over 7 Million Girls With HPV Vaccine
[Premium Times] The statement noted that a five-day mass vaccination campaign in schools and communities will be carried out during the inaugural roll-out in 16 states and the Federal Capital Territory. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 25, 2023 Category: African Health Tags: Health and Medicine Nigeria West Africa Source Type: news

Nigeria: Nigeria to Vaccinate 7.7 Million Girls Against Leading Cause of Cervical Cancer
[Africa Renewal] This is the third most common cancer and the second most frequent cause of cancer deaths among women aged between 15 and 44 years (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 25, 2023 Category: African Health Tags: Health and Medicine Nigeria West Africa Source Type: news

Antibody-Drug Conjugate Boosts Survival in Recurrent/Metastatic Cervical Cancer
(MedPage Today) -- MADRID -- Treatment with tisotumab vedotin (Tivdak) significantly extended overall survival (OS) compared with chemotherapy in patients with recurrent or metastatic cervical cancer, the phase III randomized innovaTV 301 study... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 23, 2023 Category: Hematology Source Type: news

'Practice-Changing' Data in Locally Advanced Cervical Cancer
(MedPage Today) -- MADRID -- Results from a pair of international phase III trials testing two distinct treatment strategies will usher in new standards of care for women with newly diagnosed, locally advanced cervical cancer, researchers reported... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 23, 2023 Category: Hematology Source Type: news

Biggest cervical cancer drug advance in 20 years hailed
Using existing drugs differently may be the biggest treatment breakthrough for decades, say scientists. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 23, 2023 Category: Consumer Health News Source Type: news

New cervical cancer drugs breakthrough could boost survival rates
Using a drug to destroy as many cancer cells as possible - before chemoradiation could cut rates of relapse and death. (Source: Daily Express - Health)
Source: Daily Express - Health - October 23, 2023 Category: Consumer Health News Source Type: news

Pioneering therapy cuts risk of cervical cancer by up to 35%
A study from University College London found cervical cancer patients who received an initial course of drugs before treatment were a third less likely to die. (Source: the Mail online | Health)
Source: the Mail online | Health - October 22, 2023 Category: Consumer Health News Source Type: news

Does Adding Pembro Improve PFS in High-Risk Cervical Cancer? Does Adding Pembro Improve PFS in High-Risk Cervical Cancer?
Pembrolizumab improved progression-free survival when added to standard chemoradiotherapy in newly diagnosed, locally advanced cervical cancer, new data show.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 22, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Already approved drugs could cut risk of cervical cancer return, study finds
Trial involved short course of induction chemotherapy before standard chemoradiation treatmentUse of existing drugs before the standard treatment for cervical cancer could lead to a reduction of about one-third in the risk of the disease recurring or causing death, the results of a study suggest.Researchers assessed whether a short course of induction chemotherapy (IC), using cheap, already approved drugs to destroy as many cancer cells as possible, could reduce rates of relapse and death if administered before chemoradiation (CRT), a combination of chemotherapy and radiotherapy.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - October 22, 2023 Category: Science Authors: Haroon Siddique and agency Tags: Cervical cancer Cancer research Medical research Science Society UK news Health Source Type: news